Integra LifeSciences receives ‘hold’ rating — 4 facts

Zacks analysts upgraded Integra LifeSciences stock from a “sell” rating to a “hold” rating, according to The Market Business.

Advertisement

Here are four facts:

 

1. On Wed., Sept. 30, the company’s stock traded up 0.13 percent, reaching $59.55.

 

2. Integra LifeSciences has a 50-day moving average of $62.16 and a 200-day moving average of $60.28.

 

3. The company’s 52-week low is $42.09 and 52-week high is $68.46.

 

4. Integra LifeSciences has a market cap of $1.97 billion and a P/E ratio of $49.05.

 

More articles on orthopedics:
Drs. James Andrews, Christopher E. Baker & more — 10 orthopedic surgeons to know
Dr. Brian Weatherford joins Illinois Bone & Joint Institute: 4 things to know
Dr. Donald Gajewski joins Mission Health: 4 points

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.